You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 10, October 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Oral Bases on Enteral Aluminum Absorption

John A. Walker, MD; Richard A. Sherman, MD; Ronald P. Cody, EdD

Arch Intern Med. 1990;150(10):2037-2039.


Abstract

• Physicochemical considerations suggest that citrate may potentiate gastrointestinal aluminum absorption via the formation of an aluminum citrate moiety. We tested this hypothesis and also studied whether sodium bicarbonate would have a similar effect. Eight healthy adults each partook of four oral regimens: aluminum alone, aluminum plus sodium bicarbonate, aluminum plus citrate (as Shohl's solution), and citrate alone. Twenty-four hour urine collections were obtained immediately preceeding and during the second day of each medication period for determination of aluminum content. A significant but similar increment in urinary aluminum occurred with both aluminum alone and aluminum plus sodium bicarbonate, while only a small increment was noted with Shohl's solution alone. The rise in urinary aluminum obtained with aluminum plus Shohl's solution, however, was nearly eight times that seen with either aluminum alone or aluminum plus sodium bicarbonate (327 µg vs 45 µg and 41 µg, respectively). Citrate thus appears to augment gastrointestinal aluminum absorption markedly, an effect not shared by an equivalent dose of sodium bicarbonate. Citrate administration to patients with renal failure who are also taking aluminum-containing medication may be harmful.

(Arch Intern Med. 1990;150:2037-2039)



Author Affiliations

From the Department of Medicine, Division of Nephrology and the Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick.


Footnotes

Accepted for publication March 30,1990.

This work has been published in part in abstract form in the Proceedings of the 10th International Congress of Nephrology, London, England, July 26-31, 1987.

Reprint requests to the Department of Medicine, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School CN-19, New Brunswick, NJ 08903-0019 (Dr Walker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Top 10 Things Nephrologists Wish Every Primary Care Physician Knew
Paige and Nagami
Mayo Clin Proc. 2009;84:180-186.
ABSTRACT | FULL TEXT  

Annual Review of Cosmetic Ingredient Safety Assessments--2004/2005
International Journal of Toxicology 2006;25:1-89.
FULL TEXT  

An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate
Yang et al.
Nephrol Dial Transplant 2002;17:265-270.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.